Gilead Sciences has agreed to purchase the remainder of improvement accomplice Arcellx in a deal that values the biotechnology firm at about $7.8 billion at closing.
Source link
Gilead Sciences to Buy Arcellx in Deal Valued at $7.8 Billion
Related Posts
Maine Governor Vetoes Bill to Temporarily Ban Data Centers
Janet Mills was initially supportive however needed an exemption, which the state legislature voted in opposition to. Source link
What Being an 80-Year-Old for a Day Teaches You About Aging
Plus, drone swarms, space habitat makeovers and AI literacy, in this edition of The Future of Everything newsletter. Source link
New Mexico seeking changes to Meta’s platform after jury verdict
New Mexico is continuous to hunt adjustments from Meta following a jury’s resolution to carry the corporate chargeable for failing…